TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
XFOR

X4 Pharmaceuticals Inc

Healthcare · Biotechnology

2.80$ -2.4% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow XFOR
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-1,034.92 -1,634.98 -14,599.79 -55.38 -125.03 -87.89 -82.61 -36.41 -16.28 -19.53 -2.02
38.27 22.67 102.15 0.22 0.27 1.84 2.20 0.24 0.07 0.12 0.03
12.06 48.66 474.59 12.24 5.33 8.11 7.20 2.46 1.47 1.22 0.10
– 39.06 -97.96 9.75 18.71 9.70 22.47 2.91 – – –
138.46 -39.06 1,793.61 6.83 -8.42 -6.07 -1.75 2.71 0.06 0.40 -0.06
16.27 5.52 22.00 0.07 0.45 2.04 0.72 0.05 0.01 1.09 0.07
-23.63 -10.43 -22.00 -0.07 70.86 -2.04 -0.72 -0.05 -2.51 10.00 0.19
– – 23,929.81 – 51.91 18.51 16.24 0.00 – – –
-1.15 -6.57 -103.20 -2.45 51.91 -0.41 -2.33 0.00 0.00 – –
– 453.34 3,143.01 7.69 1.25 18.51 0.00 -0.38 3.45 2.98 0.00
1,100.85 1,371.14 53,044.53 14.97 365.99 18.52 86.50 55.36 14.93 3.03 5.64
646.73 -281.38 38,636.98 -149.58 311.16 -70.55 3.28 18.85 -3.84 -6.53 3.82
-1,051.19 -1,640.50 -14,621.79 -55.38 -125.49 -89.92 -83.33 -36.46 -16.29 -20.62 -2.10

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?